Fibromyalgia Drugs Market, Global Outlook and Forecast 2023-2029

Publisher Name :
Date: 31-Jan-2023
No. of pages: 61

Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure.

This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Drugs. This report contains market size and forecasts of Fibromyalgia Drugs in global, including the following market information:

Global Fibromyalgia Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global top five companies in 2022 (%)

The global Fibromyalgia Drugs market was valued at US$ 2945.2 million in 2022 and is projected to reach US$ 3308.4 million by 2029, at a CAGR of 1.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fibromyalgia Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Fibromyalgia Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)

Global Fibromyalgia Drugs Market Segment Percentages, by Type, 2022 (%)

- Serotonin Norepinephrine Reuptake Inhibitors

- GABA Analogs

- Other

Global Fibromyalgia Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)

Global Fibromyalgia Drugs Market Segment Percentages, by Application, 2022 (%)

- Hospitals

- Clinics

- Other

Global Fibromyalgia Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)

Global Fibromyalgia Drugs Market Segment Percentages, By Region and Country, 2022 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Fibromyalgia Drugs revenues in global market, 2018-2023 (estimated), ($ millions)

Key companies Fibromyalgia Drugs revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Pfizer

- Eli Lilly

- Actavis

- Merck Sharp and Dohme

- Daiichi Sankyo

- Innovative Med Concepts

- Meda

- Meiji Seika

- Switch Biotech

- Theravance

- Zynerba Pharmaceuticals

- Tonix Pharmaceuticals Holding Corp. (TNXP)

Outline of Major Chapters:

Chapter 1: Introduces the definition of Fibromyalgia Drugs, market overview.

Chapter 2: Global Fibromyalgia Drugs market size in revenue.

Chapter 3: Detailed analysis of Fibromyalgia Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Fibromyalgia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

Fibromyalgia Drugs Market, Global Outlook and Forecast 2023-2029

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Fibromyalgia Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fibromyalgia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fibromyalgia Drugs Overall Market Size
2.1 Global Fibromyalgia Drugs Market Size: 2022 VS 2029
2.2 Global Fibromyalgia Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fibromyalgia Drugs Players in Global Market
3.2 Top Global Fibromyalgia Drugs Companies Ranked by Revenue
3.3 Global Fibromyalgia Drugs Revenue by Companies
3.4 Top 3 and Top 5 Fibromyalgia Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Fibromyalgia Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fibromyalgia Drugs Players in Global Market
3.6.1 List of Global Tier 1 Fibromyalgia Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Fibromyalgia Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Fibromyalgia Drugs Market Size Markets, 2022 & 2029
4.1.2 Serotonin Norepinephrine Reuptake Inhibitors
4.1.3 GABA Analogs
4.1.4 Other
4.2 By Type - Global Fibromyalgia Drugs Revenue & Forecasts
4.2.1 By Type - Global Fibromyalgia Drugs Revenue, 2018-2023
4.2.2 By Type - Global Fibromyalgia Drugs Revenue, 2024-2029
4.2.3 By Type - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fibromyalgia Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Fibromyalgia Drugs Revenue & Forecasts
5.2.1 By Application - Global Fibromyalgia Drugs Revenue, 2018-2023
5.2.2 By Application - Global Fibromyalgia Drugs Revenue, 2024-2029
5.2.3 By Application - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Fibromyalgia Drugs Market Size, 2022 & 2029
6.2 By Region - Global Fibromyalgia Drugs Revenue & Forecasts
6.2.1 By Region - Global Fibromyalgia Drugs Revenue, 2018-2023
6.2.2 By Region - Global Fibromyalgia Drugs Revenue, 2024-2029
6.2.3 By Region - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Fibromyalgia Drugs Revenue, 2018-2029
6.3.2 US Fibromyalgia Drugs Market Size, 2018-2029
6.3.3 Canada Fibromyalgia Drugs Market Size, 2018-2029
6.3.4 Mexico Fibromyalgia Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Fibromyalgia Drugs Revenue, 2018-2029
6.4.2 Germany Fibromyalgia Drugs Market Size, 2018-2029
6.4.3 France Fibromyalgia Drugs Market Size, 2018-2029
6.4.4 U.K. Fibromyalgia Drugs Market Size, 2018-2029
6.4.5 Italy Fibromyalgia Drugs Market Size, 2018-2029
6.4.6 Russia Fibromyalgia Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Fibromyalgia Drugs Market Size, 2018-2029
6.4.8 Benelux Fibromyalgia Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Fibromyalgia Drugs Revenue, 2018-2029
6.5.2 China Fibromyalgia Drugs Market Size, 2018-2029
6.5.3 Japan Fibromyalgia Drugs Market Size, 2018-2029
6.5.4 South Korea Fibromyalgia Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Fibromyalgia Drugs Market Size, 2018-2029
6.5.6 India Fibromyalgia Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Fibromyalgia Drugs Revenue, 2018-2029
6.6.2 Brazil Fibromyalgia Drugs Market Size, 2018-2029
6.6.3 Argentina Fibromyalgia Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Fibromyalgia Drugs Revenue, 2018-2029
6.7.2 Turkey Fibromyalgia Drugs Market Size, 2018-2029
6.7.3 Israel Fibromyalgia Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Fibromyalgia Drugs Market Size, 2018-2029
6.7.5 UAE Fibromyalgia Drugs Market Size, 2018-2029
7 Fibromyalgia Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Fibromyalgia Drugs Major Product Offerings
7.1.4 Pfizer Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Fibromyalgia Drugs Major Product Offerings
7.2.4 Eli Lilly Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Actavis
7.3.1 Actavis Company Summary
7.3.2 Actavis Business Overview
7.3.3 Actavis Fibromyalgia Drugs Major Product Offerings
7.3.4 Actavis Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.3.5 Actavis Key News & Latest Developments
7.4 Merck Sharp and Dohme
7.4.1 Merck Sharp and Dohme Company Summary
7.4.2 Merck Sharp and Dohme Business Overview
7.4.3 Merck Sharp and Dohme Fibromyalgia Drugs Major Product Offerings
7.4.4 Merck Sharp and Dohme Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.4.5 Merck Sharp and Dohme Key News & Latest Developments
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Company Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Fibromyalgia Drugs Major Product Offerings
7.5.4 Daiichi Sankyo Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.5.5 Daiichi Sankyo Key News & Latest Developments
7.6 Innovative Med Concepts
7.6.1 Innovative Med Concepts Company Summary
7.6.2 Innovative Med Concepts Business Overview
7.6.3 Innovative Med Concepts Fibromyalgia Drugs Major Product Offerings
7.6.4 Innovative Med Concepts Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.6.5 Innovative Med Concepts Key News & Latest Developments
7.7 Meda
7.7.1 Meda Company Summary
7.7.2 Meda Business Overview
7.7.3 Meda Fibromyalgia Drugs Major Product Offerings
7.7.4 Meda Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.7.5 Meda Key News & Latest Developments
7.8 Meiji Seika
7.8.1 Meiji Seika Company Summary
7.8.2 Meiji Seika Business Overview
7.8.3 Meiji Seika Fibromyalgia Drugs Major Product Offerings
7.8.4 Meiji Seika Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.8.5 Meiji Seika Key News & Latest Developments
7.9 Switch Biotech
7.9.1 Switch Biotech Company Summary
7.9.2 Switch Biotech Business Overview
7.9.3 Switch Biotech Fibromyalgia Drugs Major Product Offerings
7.9.4 Switch Biotech Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.9.5 Switch Biotech Key News & Latest Developments
7.10 Theravance
7.10.1 Theravance Company Summary
7.10.2 Theravance Business Overview
7.10.3 Theravance Fibromyalgia Drugs Major Product Offerings
7.10.4 Theravance Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.10.5 Theravance Key News & Latest Developments
7.11 Zynerba Pharmaceuticals
7.11.1 Zynerba Pharmaceuticals Company Summary
7.11.2 Zynerba Pharmaceuticals Business Overview
7.11.3 Zynerba Pharmaceuticals Fibromyalgia Drugs Major Product Offerings
7.11.4 Zynerba Pharmaceuticals Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.11.5 Zynerba Pharmaceuticals Key News & Latest Developments
7.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
7.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Summary
7.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
7.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Major Product Offerings
7.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Fibromyalgia Drugs Market Opportunities & Trends in Global Market
Table 2. Fibromyalgia Drugs Market Drivers in Global Market
Table 3. Fibromyalgia Drugs Market Restraints in Global Market
Table 4. Key Players of Fibromyalgia Drugs in Global Market
Table 5. Top Fibromyalgia Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Fibromyalgia Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Fibromyalgia Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Fibromyalgia Drugs Product Type
Table 9. List of Global Tier 1 Fibromyalgia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fibromyalgia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Fibromyalgia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Fibromyalgia Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Fibromyalgia Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application - Global Fibromyalgia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Fibromyalgia Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Fibromyalgia Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region - Global Fibromyalgia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Fibromyalgia Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Fibromyalgia Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Fibromyalgia Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Fibromyalgia Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Fibromyalgia Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Fibromyalgia Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Fibromyalgia Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Fibromyalgia Drugs Product Offerings
Table 32. Pfizer Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Fibromyalgia Drugs Product Offerings
Table 36. Eli Lilly Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. Actavis Company Summary
Table 39. Actavis Fibromyalgia Drugs Product Offerings
Table 40. Actavis Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Actavis Key News & Latest Developments
Table 42. Merck Sharp and Dohme Company Summary
Table 43. Merck Sharp and Dohme Fibromyalgia Drugs Product Offerings
Table 44. Merck Sharp and Dohme Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Sharp and Dohme Key News & Latest Developments
Table 46. Daiichi Sankyo Company Summary
Table 47. Daiichi Sankyo Fibromyalgia Drugs Product Offerings
Table 48. Daiichi Sankyo Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Daiichi Sankyo Key News & Latest Developments
Table 50. Innovative Med Concepts Company Summary
Table 51. Innovative Med Concepts Fibromyalgia Drugs Product Offerings
Table 52. Innovative Med Concepts Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Innovative Med Concepts Key News & Latest Developments
Table 54. Meda Company Summary
Table 55. Meda Fibromyalgia Drugs Product Offerings
Table 56. Meda Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Meda Key News & Latest Developments
Table 58. Meiji Seika Company Summary
Table 59. Meiji Seika Fibromyalgia Drugs Product Offerings
Table 60. Meiji Seika Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Meiji Seika Key News & Latest Developments
Table 62. Switch Biotech Company Summary
Table 63. Switch Biotech Fibromyalgia Drugs Product Offerings
Table 64. Switch Biotech Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Switch Biotech Key News & Latest Developments
Table 66. Theravance Company Summary
Table 67. Theravance Fibromyalgia Drugs Product Offerings
Table 68. Theravance Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Theravance Key News & Latest Developments
Table 70. Zynerba Pharmaceuticals Company Summary
Table 71. Zynerba Pharmaceuticals Fibromyalgia Drugs Product Offerings
Table 72. Zynerba Pharmaceuticals Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Zynerba Pharmaceuticals Key News & Latest Developments
Table 74. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Summary
Table 75. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Product Offerings
Table 76. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Tonix Pharmaceuticals Holding Corp. (TNXP) Key News & Latest Developments
List of Figures
Figure 1. Fibromyalgia Drugs Segment by Type in 2022
Figure 2. Fibromyalgia Drugs Segment by Application in 2022
Figure 3. Global Fibromyalgia Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fibromyalgia Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fibromyalgia Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fibromyalgia Drugs Revenue in 2022
Figure 8. By Type - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Fibromyalgia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Fibromyalgia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 16. US Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 28. China Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Actavis Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Sharp and Dohme Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Daiichi Sankyo Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Innovative Med Concepts Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Meda Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Meiji Seika Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Switch Biotech Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Theravance Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Zynerba Pharmaceuticals Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs